Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Daichi Nishiyama
Epstein-Barr Virus-Associated Lymphoproliferative Disease During Imatinib Mesylate Treatment for Chronic Myeloid Leukemia
Haematologica
Hematology
Related publications
Optimal Treatment for Chronic Active Epstein-Barr Virus Disease
Pediatric Transplantation
Child Health
Transplantation
Pediatrics
Perinatology
Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases
Frontiers in Pediatrics
Child Health
Pediatrics
Perinatology
Soluble CD30: A Serum Marker for Epstein-Barr Virus-Associated Lymphoproliferative Diseases
Journal of Medical Virology
Virology
Infectious Diseases
Micro-Rna Response to Imatinib Mesylate in Patients With Chronic Myeloid Leukemia
Haematologica
Hematology
Development of Multiple Myeloma in a Patient With Chronic Myeloid Leukemia After Treatment With Imatinib Mesylate
Oncologist
Cancer Research
Medicine
Oncology
Reduced-Intensity Allogeneic Transplantation Combined With Imatinib Mesylate for Chronic Myeloid Leukemia in First Chronic Phase
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Characterization of Epstein-Barr Virus Genomes in Transplant Lymphoma/Lymphoproliferative Disease
Pediatric Research
Child Health
Pediatrics
Perinatology
Epstein-Barr Virus-Associated Γδ T-Cell Lymphoproliferative Disorder Associated With Hypomorphic IL2RG Mutation
Frontiers in Pediatrics
Child Health
Pediatrics
Perinatology
Dasatinib in the Treatment of Imatinib Refractory Chronic Myeloid Leukemia
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy